Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Inventory (2022 - 2025)

Historic Inventory for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $5.7 million.

  • Immunocore Holdings' Inventory rose 2516.6% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 2516.6%. This contributed to the annual value of $5.4 million for FY2024, which is 2099.53% up from last year.
  • As of Q3 2025, Immunocore Holdings' Inventory stood at $5.7 million, which was up 2516.6% from $5.5 million recorded in Q2 2025.
  • Immunocore Holdings' Inventory's 5-year high stood at $6.8 million during Q1 2025, with a 5-year trough of $692000.0 in Q4 2022.
  • Moreover, its 4-year median value for Inventory was $4.5 million (2024), whereas its average is $4.5 million.
  • Its Inventory has fluctuated over the past 5 years, first soared by 55043.35% in 2023, then soared by 2099.53% in 2024.
  • Quarter analysis of 4 years shows Immunocore Holdings' Inventory stood at $692000.0 in 2022, then skyrocketed by 550.43% to $4.5 million in 2023, then rose by 21.0% to $5.4 million in 2024, then grew by 3.84% to $5.7 million in 2025.
  • Its last three reported values are $5.7 million in Q3 2025, $5.5 million for Q2 2025, and $6.8 million during Q1 2025.